Berndt; Sandra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Berndt; Sandra.The latest application filed is for "substituted pyrrolopyridine-derivatives".

Company Profile

4.10.16

Berndt; Sandra - Hohen Neuendorf DE
Berndt; Sandra - Cupertino CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Specific antibody drug conjugates (ADCs) having KSP inhibitors Grant 11,433,140 - Lerchen , et al. September 6, 2	2022-09-06
Substituted pyrrolopyridine-derivatives Grant 11,427,578 - Mowat , et al. August 30, 2	2022-08-30
CCR8 antibodies for therapeutic applications Grant 11,427,640 - Berndt , et al. August 30, 2	2022-08-30
Substituted Pyrrolopyridine-derivatives App 20220047603 - MOWAT; Jeffrey Stuart ; et al.	2022-02-17
Antibody Drug Conjugates (adcs) Having Enzymatically Cleavable Groups App 20220016258 - LERCHEN; Hans-Georg ; et al.	2022-01-20
Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups Grant 11,123,439 - Lerchen , et al. September 21, 2	2021-09-21
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies Grant 11,071,788 - Lerchen , et al. July 27, 2	2021-07-27
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Antib7h3-antibodies App 20200138970 - LERCHEN; Hans-Georg ; et al.	2020-05-07
Specific Antibody Drug Conjugates (adcs) Having Ksp Inhibitors App 20190365916 - LERCHEN; Hans-Georg ; et al.	2019-12-05
Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies Grant 10,485,880 - Lerchen , et al. Nov	2019-11-26
Antibody Drug Conjugates (adcs) Having Enzymatically Cleavable Groups App 20190328897 - LERCHEN; Hans-Georg ; et al.	2019-10-31
Prodrugs Of Cytotoxic Active Agents Having Enzymatically Cleavable Groups App 20190077752 - LERCHEN; Hans-Georg ; et al.	2019-03-14
Operating system context switching Grant 10,127,073 - Princen , et al. November 13, 2	2018-11-13
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Anti-tweakr-antibodies App 20180318438 - LERCHEN; Hans-Georg ; et al.	2018-11-08
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) Grant 10,022,453 - Lerchen , et al. July 17, 2	2018-07-17
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Anti-b7h3-antibodies App 20180185510 - LERCHEN; Hans-Georg ; et al.	2018-07-05
Antibody Drug Conjugates (adcs) And Antibody Prodrug Conjugates (apdcs) With Enzymatically Cleavable Groups App 20180169256 - LERCHEN; Hans-Georg ; et al.	2018-06-21
Antibody-drug Conjugates (adcs) Of Ksp Inhibitors With Aglycosylated Anti-tweakr Antibodies App 20180015176 - LERCHEN; Hans-Georg ; et al.	2018-01-18
Operating System Context Switching App 20170097846 - Princen; John ; et al.	2017-04-06
Antibody Drug Conjugates (adcs) With Kinesin Spindel Protein (ksp) App 20160346402 - LERCHEN; Hans-Georg ; et al.	2016-12-01
Anti-tweakr Antibodies And Uses Thereof App 20160237160 - VOTSMEIER; Christian ; et al.	2016-08-18
Operating System Context Switching App 20130232327 - Princen; John ; et al.	2013-09-05
Cloud Remote Wakeup App 20130212413 - BERNDT; Sandra ; et al.	2013-08-15
Operating system context switching Grant 8,433,889 - Princen , et al. April 30, 2	2013-04-30
Operating System Context Switching App 20110271088 - Princen; John ; et al.	2011-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.